Display options
Cite
Pandey S, Pandey P, Tiwari G, et al. Bioanalysis in drug discovery and development. Pharm Methods. 2010;1(1):14-24doi: 10.4103/2229-4708.72223.
Pandey, S., Pandey, P., Tiwari, G., & Tiwari, R. (2010). Bioanalysis in drug discovery and development. Pharmaceutical methods, 1(1), 14-24. https://doi.org/10.4103/2229-4708.72223
Pandey, Saurabh, et al. "Bioanalysis in drug discovery and development." Pharmaceutical methods vol. 1,1 (2010): 14-24. doi: https://doi.org/10.4103/2229-4708.72223
Pandey S, Pandey P, Tiwari G, Tiwari R. Bioanalysis in drug discovery and development. Pharm Methods. 2010 Oct;1(1):14-24. doi: 10.4103/2229-4708.72223. PMID: 23781412; PMCID: PMC3658019.
Copy Download .nbib Format: NLM
Share it on

Pharm Methods. 2010 Oct;1(1):14-24. doi: 10.4103/2229-4708.72223.

Bioanalysis in drug discovery and development.

Pharmaceutical methods

Saurabh Pandey, Preeti Pandey, Gaurav Tiwari, Ruchi Tiwari

Affiliations

  1. Pranveer Singh Institute of Technology, Bhauti, Kanpur, Uttar Pradesh, India.

PMID: 23781412 PMCID: PMC3658019 DOI: 10.4103/2229-4708.72223

Abstract

Recent years have witnessed the introduction of several high-quality review articles into the literature covering various scientific and technical aspects of bioanalysis. Now it is widely accepted that bioanalysis is an integral part of the pharmacokinetic/pharmacodynamic characterization of a novel chemical entity from the time of its discovery and during various stages of drug development, leading to its market authorization. In this compilation, the important bioanalytical parameters and its application to drug discovery and development approaches are discussed, which will help in the development of safe and more efficacious drugs with reduced development time and cost. It is intended to give some general thoughts in this area which will form basis of a general framework as to how one would approach bioanalysis from inception (i.e., discovery of a lead molecule) and progressing through various stages of drug development.

Keywords: Bioanalytical; metabolism; method validation; pharmacokinetics; toxicokinetic

References

  1. J Clin Oncol. 2008 Apr 10;26(11):1871-8 - PubMed
  2. J Pharm Biomed Anal. 2009 Dec 5;50(5):977-82 - PubMed
  3. J Clin Oncol. 2008 Jan 20;26(3):399-405 - PubMed
  4. Biochem Pharmacol. 1994 Apr 29;47(9):1469-79 - PubMed
  5. J Mass Spectrom. 2003 Apr;38(4):357-72 - PubMed
  6. Biomed Chromatogr. 2008 May;22(5):535-41 - PubMed
  7. Drug Metab Rev. 1996 Aug;28(3):473-89 - PubMed
  8. Toxicol Pathol. 1994 Mar-Apr;22(2):112-23 - PubMed
  9. J Chromatogr. 1990 Oct 12;531:3-50 - PubMed
  10. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Oct 25;825(2):134-43 - PubMed
  11. J Pharm Biomed Anal. 2006 Feb 24;40(3):720-7 - PubMed
  12. Rapid Commun Mass Spectrom. 1999;13(23):2305-19 - PubMed
  13. J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Jun 1;852(1-2):77-84 - PubMed
  14. J Pharm Biomed Anal. 1998 Jun;17(2):193-218 - PubMed
  15. Nat Rev Drug Discov. 2005 Oct;4(10):825-33 - PubMed
  16. Rapid Commun Mass Spectrom. 2007;21(9):1531-40 - PubMed
  17. J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Apr 15;877(11-12):1185-92 - PubMed
  18. J Pharm Biomed Anal. 1996 Feb;14(4):375-88 - PubMed
  19. J Sep Sci. 2010 Jan;33(1):23-30 - PubMed
  20. Drug Discov Today. 2003 Feb 1;8(3):127-33 - PubMed
  21. Biomed Chromatogr. 2010 Jul;24(7):692-8 - PubMed
  22. J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Mar 15;864(1-2):52-60 - PubMed
  23. Pharm Res. 1991 Apr;8(4):421-6 - PubMed
  24. Nat Rev Drug Discov. 2004 Aug;3(8):711-5 - PubMed
  25. Eur J Drug Metab Pharmacokinet. 1991 Oct-Dec;16(4):249-55 - PubMed
  26. Pharmacol Rev. 1997 Dec;49(4):403-49 - PubMed
  27. Nat Rev Drug Discov. 2007 Feb;6(2):140-8 - PubMed
  28. Br J Clin Pharmacol. 1988 Mar;25(3):387-96 - PubMed
  29. Drug Discov Today. 2000 Sep;5(9):409-414 - PubMed
  30. Pharm Res. 2000 Dec;17(12):1551-7 - PubMed
  31. Drug Metab Dispos. 2001 Oct;29(10):1316-24 - PubMed
  32. Rapid Commun Mass Spectrom. 2007;21(5):635-43 - PubMed
  33. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Jul 25;821(2):173-80 - PubMed
  34. Ther Drug Monit. 2007 Feb;29(1):103-9 - PubMed
  35. J Pharm Biomed Anal. 2006 Mar 18;40(5):1218-24 - PubMed
  36. J Pharm Biomed Anal. 1995 Dec;14(1-2):23-31 - PubMed
  37. J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Jan 2;830(1):143-50 - PubMed
  38. Toxicol Appl Pharmacol. 2010 Mar 15;243(3):340-7 - PubMed
  39. J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Jun 15;853(1-2):70-9 - PubMed
  40. Pharm Res. 2008 Mar;25(3):542-50 - PubMed
  41. Drug Discov Today. 2008 Apr;13(7-8):360-7 - PubMed
  42. Drug Metab Dispos. 2001 Jul;29(7):957-66 - PubMed
  43. Biomed Chromatogr. 2006 May;20(5):383-414 - PubMed
  44. J Ethnopharmacol. 2003 Feb;84(2-3):187-92 - PubMed
  45. J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Jun 1;852(1-2):582-9 - PubMed
  46. Antimicrob Agents Chemother. 1997 Nov;41(11):2339-44 - PubMed
  47. Xenobiotica. 1992 Sep-Oct;22(9-10):1195-205 - PubMed
  48. Drug Metab Dispos. 1999 Nov;27(11):1350-9 - PubMed
  49. Cancer Chemother Pharmacol. 2007 Apr;59(5):671-9 - PubMed
  50. Rapid Commun Mass Spectrom. 2000;14(18):1637-43 - PubMed
  51. Rapid Commun Mass Spectrom. 2001;15(10):741-8 - PubMed
  52. J Pharmacokinet Biopharm. 1988 Jun;16(3):279-301 - PubMed
  53. Rapid Commun Mass Spectrom. 2003;17(23):2661-8 - PubMed
  54. J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Jun 15;853(1-2):88-96 - PubMed
  55. Int J Pharm. 2000 May 25;201(2):131-50 - PubMed
  56. Biomed Chromatogr. 2007 Jul;21(7):747-54 - PubMed
  57. Biomed Chromatogr. 2006 Apr;20(4):349-57 - PubMed
  58. J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Oct 15;858(1-2):118-28 - PubMed
  59. Xenobiotica. 2001 Aug-Sep;31(8-9):591-8 - PubMed

Publication Types